SPHINGOSIN-KINASEHEMMER

European patent · EP3201181 · In force

Register entry

Publication number
EP3201181
Application number
EP15846548
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 30, 2015
Published
Aug 9, 2017
Granted
Dec 2, 2020
Protection ends at the latest
Sep 29, 2035
Next annual fee due
Sep 30, 2026
IPC classes
A61P 35/00 (2006.01)
Priority
US 201462058294 P 01.10.2014
US 201562199412 P 31.07.2015
PCT application
PCT/US2015/053315 30.09.2015
PCT publication
WO2016/054261 07.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2025

    Change

    Published in Swissreg on 01.10.2025

  2. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  3. Oct 2, 2023

    Change

    Published in Swissreg on 02.10.2023

  4. Oct 5, 2022

    Change

    Published in Swissreg on 05.10.2022

  5. Oct 13, 2021

    Change

    Published in Swissreg on 13.10.2021

  6. Apr 14, 2021

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 14.04.2021

  7. Dec 2, 2020

    Granted

    Published in Swissreg on 02.12.2020

Parties

Inventor

SANTOS, Webster L.

Blacksburg, Virginia 24060, US

LYNCH, Kevin R.

Charlottesville, Virginia 22901, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.